News
People heading to university to be offered MenB vaccine following Kent outbreak
It'll be given ahead of the 2026 academic year.
Emily Sergeant -
12th June 2026 
Thousands of young people who are heading to university this year are to be offered a two-dose MenB vaccine following the outbreak in Kent earlier this year.
Launching ahead of the 2026 academic year, and particularly concentrated on universities – where prolonged contact in halls and at social events can increase the risk of contracting the disease – the Government has confirmed that thousands of young people across England will get protection against meningococcal B disease (MenB) through a one-off vaccination programme.
Meningococcal disease is life-threatening and can result in life-changing disabilities such as amputations, hearing loss, and brain damage, and in around 10% of cases, it is fatal.
The viruses and bacteria that cause meningitis can be spread through close contact with a person who has them – for example through kissing, or sharing drinks or vapes, or having close contact with the person for long periods of time.
The MenB outbreak in Kent earlier this year was the fastest growing and largest ever seen in the UK.
While the response to that incident has now concluded, the Government has conceded that there has been more clusters on MenB ‘than normal’ this year, and some of which have been bigger than expected.
We're launching a one-off MenB vaccination programme ahead of the next academic year to protect young people from a life-threatening disease.
— Department of Health and Social Care (@DHSCgovuk) June 12, 2026
This will help reduce the risk of serious illness and larger outbreaks. Two doses are needed for full protection.
More:… pic.twitter.com/XhuCA9cw42
The UKHSA data shows that there were 313 confirmed cases of MenB in England during 2024/25, which accounts for approximately 83% of all invasive meningococcal disease (IMD) cases.
This one-off vaccination programme will help to protect those at highest immediate risk, while the Government aims to monitor and assess new evidence to determine whether there has been a change in the way MenB affects people and whether any further vaccine rollout response is required.
“The Kent outbreak and recent clusters indicate a possible change to the way MenB affects people,” explained Health Secretary, James Murray.
“While we assess the latest evidence, we are acting now to help protect young people at highest immediate risk as they enter university and residential colleges this autumn.
“By offering a two-doses of the jabs ahead of the academic year, we will help reduce the risk of serious illness and larger outbreaks of this horrendous disease.
Read more:
- NHS rolls out five-minute ‘super jab’ to treat 15 different types of cancer
- Girl, 14, charged with attempted murder after stabbing at Manchester high school
- The NHS found to be in a ‘critical condition’ following an independent investigation
“I urge all those students who are eligible to come forward for their two doses in July and August, to give them peace of mind as they head off to continue their studies.”
The one-off programme will make MenB vaccination available to people who complete year 13 of education in the summer of 2026, born between 1st September 2007 and 31st August 2008, as well as people under 25-years old starting university or moving into some residential further education settings for the first time in autumn 2026.
Featured Image – NappyStudio (via Unsplash)
